The use of recombinant factor VIIa (rVIIa, Novoseven) in the management of surgery and acute bleeding episodes in patients with high responding factor VIII inhibitors

被引:0
|
作者
机构
关键词
Tranexamic Acid; Central Venous Access Device; Novoseven; Bone Marrow Trephine; FVIII Inhibitor;
D O I
10.1007/BF03169824
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] The efficacy of recombinant factor VIIA (Novoseven) in a patient with severe factor XI deficiency and abnormal bleeding
    Dragani, A.
    Di Marzio, I
    Malizia, R.
    Iuliani, O.
    Clissa, C.
    Patriarca, A.
    Rolandi, G.
    Castaman, G.
    Davi, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 130 - 131
  • [32] Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
    Miatech, Jennifer L.
    Kantamani, Deepti
    Stagg, M. Patrick
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [33] Use of recombinant factor VIIa in the management of 3 bleeding episodes in a patient with Bernard-Soulier syndrome
    Messaoudi, R.
    Hadj, T.
    Zahia, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1152 - 1153
  • [34] Predictors of response to combination therapy with recombinant Factor VIIa and Factor VIII in patients with hemophilia A and high titer inhibitors
    Dunn, Amy L.
    Nguyen, Brenda
    Baldwin, W. Hunter
    Kenet, Gili
    Meeks, Shannon L.
    HAEMOPHILIA, 2014, 20 : 42 - 42
  • [35] Management of 2 patients with subdural hematoma and Coagulopathy with recombinant human activated Factor VII (Novoseven, rVIIa).
    Abu-Hajir, M
    Hollowell, J
    Nagargoje, G
    BLOOD, 2001, 98 (11) : 79B - 79B
  • [36] The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulant
    Billon, S
    Le Niger, C
    Escoffre-Barbe, M
    Vicariot, M
    Abgrall, JF
    BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (07) : 551 - 553
  • [37] Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait
    Kanyike, FB
    Abdul-Salam, SA
    Prakash, B
    Sharhan, A
    Wahib, N
    Youssef, AH
    HAEMOPHILIA, 1999, 5 (04) : 273 - 275
  • [38] Management of oral bleeding in third molar surgery with recombinant factor VIIa in patients with hemophilia A with high inhibitor titers and factor deficiency
    Conejo, A.
    HAEMOPHILIA, 2010, 16 : 52 - 52
  • [40] Cost-utility analysis of recombinant factor VIIa (NovoSeven®) in six children with long-standing inhibitors to factor VIII or IX
    Ekert, H
    Brewin, T
    Boey, W
    Davey, P
    Tilden, D
    HAEMOPHILIA, 2001, 7 (03) : 279 - 285